Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer

Authors

Andrew J Wilson, Vanderbilt University Medical Center
Vijayalaxmi G Gupta, Washington University School of Medicine in St. Louis
Qi Liu, Vanderbilt University Medical Center
Fiona Yull, Vanderbilt University
Marta A Crispens, Vanderbilt University Medical Center
Dineo Khabele, Washington University School of Medicine in St. Louis

Journal

Neoplasia

Publication Date

2-1-2022

Volume

24

Issue

2

First Page

63

Last Page

75

Document Type

Open Access Publication

DOI

10.1016/j.neo.2021.12.002

Rights and Permissions

Wilson AJ, Gupta VG, Liu Q, Yull F, Crispens MA, Khabele D. Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer. Neoplasia. 2022 Feb;24(2):63-75. doi: 10.1016/j.neo.2021.12.002. © 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) https://doi.org/10.1016/j.neo.2021.12.002

Recommended Citation

Wilson, Andrew J; Gupta, Vijayalaxmi G; Liu, Qi; Yull, Fiona; Crispens, Marta A; and Khabele, Dineo, "Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer." Neoplasia. 24, 2. 63 - 75. (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11502